ÂÜÀòÂÒÂ×

Aleksei (Alex) Zeifman is an experienced investment manager and board director with a strong focus on the biotechnology sector. Currently serving as a Non-Executive Director at Asgard Therapeutics and a Board Director at Valink Therapeutics, Zeifman also holds the position of Investment Manager at both Vetter Pharma and RV Invest. Previous roles include managing investment portfolios at SCOR, consulting for Roche on business optimization, and contributing as a board observer at Immusoft Corporation. With a robust academic background including a PhD in Chemistry and an MBA from Mannheim Business School, Zeifman has expertise in identifying and evaluating investment opportunities in HealthTech and InsurTech, developing strategic investment portfolios, and fostering company growth at the board level.